Scientists at the University of Southampton have created a new method that could be useful for rapidly identifying infectious bacteria…
Articles by Marisa Wexler, MS
A natural compound called ectoine may help to improve the stability of the CFTR protein by modulating the activity…
Health Canada has expanded the approval of Vertex Pharmaceuticals‘ triple-combination modulator treatment Trikafta to cover children with cystic fibrosis…
Sionna Therapeutics, a life sciences company that is developing a pipeline of experimental treatments for cystic fibrosis (CF), has…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
As part of its Path to a Cure initiative, the Cystic Fibrosis Foundation is readying its first “Golden Ticket” Competition,…
The first participant has been enrolled in a Phase 1 clinical trial testing the safety and pharmacological properties of the…
The complex diagnostic journey of a girl with cystic fibrosis (CF) and three different disease-causing mutations was described in…
KIT2014, an experimental treatment that Kither Biotech is developing to treat cystic fibrosis (CF) and other lung diseases,…
Antibiotics are less effective at treating lung infections in cystic fibrosis (CF) when there are multiple types of infectious…